Regulated cell death pathways in doxorubicin-induced cardiotoxicity.

Christidi E, Brunham LR. · 2021

Read Regulated cell death pathways in doxorubicin-induced cardiotoxicity. by Christidi E, Brunham LR. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8017015.txt.

Description

Christidi and Brunham review the regulated cell death pathways behind doxorubicin's damage to the heart. Doxorubicin treats many cancers, but up to a quarter of patients develop cardiotoxicity. The harm can cut the heart's pumping power and end in failure. How exactly the drug kills heart muscle cells stayed elusive for years. New work has named several distinct death programs.

The review covers apoptosis, necroptosis, pyroptosis, and ferroptosis in turn. Autophagy gets its own treatment, since its role remains unclear. It may shield heart cells, or it may harm them. Sirtuins appear as protectors across several pathways. The authors ask which pathway matters most, and whether one drug could block several at once. Answers would sharpen safety testing for new cancer drugs.

Catalog record

CREATORChristidi E, Brunham LR.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE65 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8017015

Browse the full library · About the Tower of Babel